As CDMO giants Wuxi AppTec and WuXi Biologics come under mounting scrutiny for their alleged ties to Chinese government officials, they are losing a key ally in Washington, D.C. Wednesday, the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Later this month, BIO will hold its annual conference. BIO provides advocacy, business development, and communications services for its members worldwide. BIO came into existence in 1993 through the ...

Current Portfolio Allocation for Core Biotech1. Selling my stake in Abcellera Biologics (ABCL) for 18% loss2. Adding to my position in Axsome Therapeutics (AXSM), increasing portfolio weighting from 4 ...

BOSTON — While most panel discussions at the Biotechnology Innovation Organization’s international convention tend to be heavy on jargon and light on urgency, a conversation on Tuesday about the ...

Gareth Soloway's technical market breakdown: S&P 500 trend-line test, semiconductor unwind, AI-to-biotech rotation, USD/JPY ...

Psychedelic therapy developer Definium Therapeutics convinced a federal judge in Delaware on Wednesday to dismiss a lawsuit ...